Jan Skvarka, Trillium CEO
How Jan Skvarka and Trillium went from down and out to buyout with Pfizer
How do you pull off one of the most lucrative biotech turnarounds in history?
You begin, it seems, by calling up the chief business officer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
